In Vitro Diagnostics Business Outlook, 2024
ISSUE 1 OF 6 - In Vitro Diagnostics Business Outlook, Volume 3, Issue 1 - Focus on Molecular HLA Testing
(price includes 6 issues published every two months)In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually.
In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including:
Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities
- A comprehensive view of the IVD market with test categories covered and company briefs
- M&A activities, selected partnerships & collaborations, partnership deals, and more
- Industry & region watch to help tailor strategies
- Analysis of news and events and reporting on news not easily available
- MARKET ANALYSIS: MOLECULAR HLA/TRANSPLANT TESTING
- OVERVIEW OF MOLECULAR HLA/TRANSPLANT TESTING
- MARKET OUTLOOK
- REGIONAL MARKET
- TOP COMPANY BRIEFS
- Immucor
- Luminex/DiaSorin
- CareDx
- Thermo Fisher Scientific
- EXECUTIVE NEWS BRIEFING
- DEKFI DIAGNOSTICS APPOINT NEW CEO
- ONERA RAISES $32 MILLION IN FUNDING
- CLEVELAND DIAGNOSTICS COMPLETES $75 MILLION IN FUNDING
- FINANCIAL HIGHLIGHTS: AGILENT AND HOLOGIC
- AGILENT FULL YEAR FISCAL 2023 SALES UP 1.5% IN CORE BUSINESS YOY
- Figure: Agilent Sales, by Business (Agilent CrossLab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), FY 2022 and FY 2023
- Figure: Agilent Sales, by Business (Agilent CrossLab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), FY 2023 Quarterly Performance
- Table: Agilent Revenue Mix, by Type (Consumables/Services/Informatics and Instruments), FY 2023 (%)
- Figure: Agilent FY 2023 Regional Sales Breakdown Distribution, by Region (Americas, Asia Pacific, Europe) (%)
- HOLOGIC SUPPORTS STRONG FINANCIAL PERFORMANCE IN FULL-YEAR FISCAL YEAR GUIDANCE
- Table: Hologic Diagnostic Sales Performance, by Product Group (Blood Screening, Cytology & Perinatal, Molecular Diagnostics), FY 2023 ($ millions)
- Figure: Hologic Revenue, by Product Group (Blood Screening, Cytology & Perinatal, Molecular Diagnostics), FY 2022 and FY 2023 ($ millions)
- Figure: Hologic Geographic Revenue Distribution, by Region (Asia Pacific, Europe, United States, All Others), FY 2023 (%)
- DIAGNOSTIC MARKET MERGERS, ACQUISITIONS AND PARTNERSHIP DEALS
- MERGERS AND ACQUISITIONS
- Table: Selected Diagnostic Market Mergers and Acquisitions Deals
- PARTNERSHIPS AND COLLABORATIONS
- INDUSTRY WATCH
- COVID-19 UPDATE
- REGION WATCH
- INDIA
- Figure: India Real GDP Growth, Inflation Rate (consumer prices), 2017-2024
- Figure: India IVD Market Distribution of Sales, by Broad IVD Segment (Chemistry/Hematology/Coagulation, Histology/Cytology, Immunoassays, Microbiology/Virology, Point-of-Care Glucose, Other Segments), 2023 (%)
- SAUDI ARABIA
- Figure: Saudi Arabia Population Pyramid, 2023 and 2053
- Figure: Saudi Arabia Total Annual Liquid Fuels Production and Consumption, 2013-2022 (millions of barrels)
- Figure: Saudi Arabia IVD Market Share, by Broad IVD Segment (Chemistry/Hematology/Coagulation, Histology/Cytology, Immunoassays, Microbiology/Virology, Point-of-Care Glucose, Other Segments), 2023
- BROAD-BASED COMPANY ANNOUNCEMENTS
- QUIDELORTHO OBTAINS FDA NOD
- ILLUMINA PLANS TO DIVEST GRAIL
- ROCHE TO ACQUIRE LUMIRADX
- QIAGEN EXPANDS FOOTPRINT WITH NEW REGIONAL HEADQUARTERS IN MIDDLE EAST
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook